Related references
Note: Only part of the references are listed.Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates
Laura E. Via et al.
INFECTION AND IMMUNITY (2008)
The Enduring Hypoxic Response of Mycobacterium tuberculosis
Tige R. Rustad et al.
PLOS ONE (2008)
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis
Sang Hyun Cho et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity
Laura E. Swaim et al.
INFECTION AND IMMUNITY (2006)
Oxygen status of lung granulomas in Mycobacterium tuberculosis-infected mice
S. Aly et al.
JOURNAL OF PATHOLOGY (2006)
β-defensin gene expression during the course of experimental tuberculosis infection
Bruno Rivas-Santiago et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy
Digby F. Warner et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Tuberculosis
A. D. Harries et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2006)
Prevalences of Pneumocystis jiroveci, Mycobacterium tuberculosis and Streptococcus pneumoniae infection in children with severe pneumonia, in a tertiary referral hospital in northern Tanzania
J Uriyo et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2006)
Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension
MC Tsai et al.
CELLULAR MICROBIOLOGY (2006)
Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model
E Nuermberger et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses
V Lazarevic et al.
JOURNAL OF IMMUNOLOGY (2005)
Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models
AJ Lenaerts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
TNF-blocking agents and tuberculosis: new drugs illuminate an old topic
J Keane
RHEUMATOLOGY (2005)
Replication dynamics of Mycobacterium tuberculosis in chronically infected mice?
EJ Munoz-Elias et al.
INFECTION AND IMMUNITY (2005)
Superinfecting mycobacteria home to established tuberculous granulomas
CL Cosma et al.
NATURE IMMUNOLOGY (2004)
Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis
HD Park et al.
MOLECULAR MICROBIOLOGY (2003)
Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation
KN Lewis et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
The relative importance of T cell subsets in immunity and immunopathology of Airborne Mycobacterium tuberculosis infection in mice
T Mogues et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Nonreplicating persistence of Mycobacterium tuberculosis
LG Wayne et al.
ANNUAL REVIEW OF MICROBIOLOGY (2001)
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
CK Stover et al.
NATURE (2000)
A new single-copy mycobacterial plasmid, pMF1, from Mycobacterium fortuitum which is compatible with the pAL5000 replicon
G Bachrach et al.
MICROBIOLOGY-UK (2000)
Share Paper
